Concepedia

Ofri Mosenzon

OM

Statistics

Publications

99

Citations

23.2K

H-Index

52

Active since

2003

Affiliations

Hebrew University of Jerusalem(Current)

Hadassah Medical Center

Thrombolysis in Myocardial Infarction Study Group

Brigham and Women's Hospital

The University of Texas Southwestern Medical Center

Ofri Mosenzon is an author at Hebrew University of Jerusalem specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Publications per year

2003–2023

99

Publications

99

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott, Itamar Raz, Marc P. Bonaca et al. · New England Journal of Medicine · 2018 · 6.3K citations · Full text

, , +17

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 3.5K citations · Full text

, , +14

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Mansoor Husain, Andreas L. Birkenfeld, Morten Donsmark et al. · New England Journal of Medicine · 2019 · 1.9K citations · Full text

, , +16

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity

Domenica Rubino, Niclas Abrahamsson, Melanie J. Davies et al. · JAMA · 2021 · 1.2K citations · Full text

, , +17

Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial

Patrick M. O’Neil, Andreas L. Birkenfeld, Barbara McGowan et al. · The Lancet · 2018 · 804 citations

, , +13

1–5 of 99